CCN1 and gastric cancer: These results suggest that CYR61 may be implicated in MDR through the upregulation of MRP1 in gastric cancer, and that the effect of quercetin on drug resistance in AGS-cyr61 cells may be due to MRP1 protein expression inhibition.